| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.0048 | 1 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.00047 | 1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.00054 | 1 |